Skip to content

Clinical trials

Phase 3 Pulmonary Arterial Hypertension trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 3 Country / region: Belgium Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20062
20071
20083
20093
20103
20113
20163
20171
20181
20192
20201
20214
20223
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated9
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion10
United Therapeutics7
Novartis Pharmaceuticals4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Bayer2
Biogen2
Aerovate Therapeutics1
Bellerophon Pulse Technologies1
GB002, Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension36
Hypertension, Pulmonary16
Hypertension4
Cardiovascular Diseases2
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Respiratory Tract Diseases2
Vascular Diseases2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.